Education
About Us
Working with TipRanks
Follow Us
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.70M | $ 1.04M | $ 4.01M | $ 4.74M | $ 1.08M |
| Gross Profit | $ 2.73M | $ 1.04M | $ 4.01M | $ 4.74M | $ 1.08M |
| Operating Income | $ -516.77M | $ -338.85M | $ -222.61M | $ -167.88M | $ -107.70M |
| EBITDA | $ -461.25M | $ -336.07M | $ -221.51M | $ -166.90M | $ -106.78M |
| Net Income | $ -465.32M | $ -298.41M | $ -214.53M | $ -163.92M | $ -107.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.03B | $ 1.35B | $ 558.55M | $ 334.43M | $ 333.71M |
| Total Assets | $ 1.14B | $ 1.43B | $ 635.35M | $ 352.18M | $ 351.01M |
| Total Debt | $ 48.54M | $ 51.72M | $ 51.73M | $ 3.08M | $ 3.07M |
| Net Debt | $ -52.99M | $ -212.82M | $ -3.17M | $ -29.60M | $ -197.62M |
| Total Liabilities | $ 143.41M | $ 109.79M | $ 96.25M | $ 35.85M | $ 19.07M |
| Stockholders' Equity | $ 992.08M | $ 1.32B | $ 539.11M | $ 316.33M | $ 331.94M |
| Cash Flow | |||||
| Free Cash Flow | $ -383.68M | $ -229.81M | $ -171.00M | $ -116.86M | $ -89.02M |
| Operating Cash Flow | $ -377.92M | $ -225.97M | $ -166.31M | $ -115.20M | $ -88.59M |
| Investing Cash Flow | $ 173.91M | $ -574.82M | $ -200.41M | $ -173.98M | $ -56.48M |
| Financing Cash Flow | $ 40.61M | $ 1.01B | $ 388.94M | $ 121.96M | $ 252.68M |